News | November 02, 2006

New York Presbyterian Rescues Hearts with New Devices

NewYork-Presbyterian Hospital now offers a new alternative therapy for heart failure patients at risk for sudden cardiac arrest. Concerto and Virtuoso implantable defibrillators-pacemakers from Medtronic will help keep the beat for patients whose heart electrical impulses for controlling chamber contractions are impaired.

Concerto and Virtuoso have the ability to send data wirelessly to the physician's computer, allowing the physician to monitor our patients remotely, utilize wireless communication using a dedicated radio-frequency called MICS that is safe from cell-phone interference, and offer the ability to detect fluid buildup in the patient's lungs and chest—often the first sign of worsening heart failure.

The devices, each the size of a stopwatch, detect any abnormal heart rhythm such as ventricular tachycardia and automatically provide a shock to correct the problem. Additionally, the Concerto synchronizes the patient's heartbeat through a painless electric impulse to help the heart pump blood throughout the body more efficiently. The Virtuoso also provides limited pacing. Both devices are programmed to meet the individual needs of each patient.

Related Content

Medtronic AdaptivCRT Feature Associated with Improved Heart Failure Patient Survival
News | Cardiac Resynchronization Therapy Devices (CRT) | May 22, 2018
Medtronic plc announced study results showing its AdaptivCRT algorithm is associated with improved patient survival....
Medtronic Recalls CRT-Ds and ICDs Due to Manufacturing Error Preventing Electrical Shock Delivery
News | Cardiac Resynchronization Therapy Devices (CRT) | February 26, 2018
The U.S. Food and Drug Administration (FDA) announced that Medtronic is recalling certain implantable cardioverter...
Abbott Announces MR-Conditional Labeling for Quadra Assura CRT-D and Fortify Assura ICD
Technology | Cardiac Resynchronization Therapy Devices (CRT) | January 03, 2018
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT) | August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT) | July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Videos | Cardiac Resynchronization Therapy Devices (CRT) | May 23, 2017
This video, provided by ERB, demonstrates the function and implantation of the WiSE CRT (Wireless Stimulation Endocar
Biotronik Announces FDA Approval of MultiPole Pacing
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 11, 2017
May 11, 2017 — Biotronik announced U.S.
Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 10, 2017
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm...
Overlay Init